Expert Review of Anticancer Therapy, Volume 23, Issue 10 (2023)

Browse this journal
Sample our Bioscience journals, sign in here to start your access, Latest two full volumes FREE to you for 14 days

Expert Review of Anticancer Therapy, Volume 23, Issue 10 (2023)

See all volumes and issues
Vol 24, 2024 Volume 23, 2023 Vol 22, 2022 Vol 21, 2021 Vol 20, 2020 Vol 19, 2019 Vol 18, 2018 Vol 17, 2017 Vol 16, 2016 Vol 15, 2015 Vol 14, 2014 Vol 13, 2013 Vol 12, 2012 Vol 11, 2011 Vol 10, 2010 Vol 9, 2009 Vol 8, 2008 Vol 7, 2007 Vol 6, 2006 Vol 5, 2005 Vol 4, 2004 Vol 3, 2003 Vol 2, 2002 Vol 1, 2001
Download citations Download PDFs Download issue

Triple negative breast cancer

Editorial

Editorial
Triple-negative breast cancers
Steven A Narod & Rebecca Dent
Pages: 1041-1043
Published online: 14 Sep 2023
First Page PreviewforTriple-negative breast cancers | Full Text | References | PDF (365.2 KB) | EPUB
  • 1189 Views
  • 0 CrossRef citations
  • 0Altmetric
Free Access
Editorial
How can we refine the prognostic stratification of triple-negative breast cancer?
Federica Miglietta & Maria Vittoria Dieci
Pages: 1045-1047
Published online: 17 Aug 2023
First Page PreviewforHow can we refine the prognostic stratification of triple-negative breast cancer? | Full Text | References | PDF (1.6 MB) | EPUB
  • 631 Views
  • 0 CrossRef citations
  • 0Altmetric
Free Access

Review

Review Article
Optimal adjuvant treatment strategies for TNBC patients with residual disease after neoadjuvant treatment
Deniz Can Guven, Hasan Cagri Yildirim, Fatih Kus, Enes Erul, Neyran Kertmen, Omer Dizdar & Sercan Aksoy
Pages: 1049-1059
Published online: 31 May 2023
AbstractforOptimal adjuvant treatment strategies for TNBC patients with residual disease after neoadjuvant treatment | Full Text | References | PDF (325.1 KB) | EPUB
  • 531 Views
  • 2 CrossRef citations
  • 0Altmetric
Review Article
The emergence of targeted therapy for HER2-low triple-negative breast cancer: a review of fam-trastuzumab deruxtecan
Anna R. Schreiber, Cindy L. O’Bryant, Peter Kabos & Jennifer R. Diamond
Pages: 1061-1069
Published online: 26 Oct 2023
AbstractforThe emergence of targeted therapy for HER2-low triple-negative breast cancer: a review of fam-trastuzumab deruxtecan | Full Text | References | PDF (1.2 MB) | EPUB
  • 359 Views
  • 0 CrossRef citations
  • 0Altmetric
Review Article
Progress in immune checkpoint inhibition in early-stage triple-negative breast cancer
Ahmed Mohamed, Megan Kruse & Jennifer Tran
Pages: 1071-1084
Published online: 26 Oct 2023
AbstractforProgress in immune checkpoint inhibition in early-stage triple-negative breast cancer | Full Text | References | PDF (382.8 KB) | EPUB
  • 320 Views
  • 0 CrossRef citations
  • 0Altmetric
Review Article
Locoregional recurrence in triple negative breast cancer: past, present, and future
Jennifer Tran, Arushi Thaper, Nerea Lopetegui-Lia & Azka Ali
Pages: 1085-1093
Published online: 26 Oct 2023
AbstractforLocoregional recurrence in triple negative breast cancer: past, present, and future | Full Text | References | PDF (290.1 KB) | EPUB
  • 360 Views
  • 0 CrossRef citations
  • 0Altmetric
Review Article
The role of immune checkpoint inhibition in triple negative breast cancer
Kidist Tarekegn, Merve Keskinkilic, Tyler J. Kristoff, Sean T. Evans & Kevin Kalinsky
Pages: 1095-1106
Published online: 26 Oct 2023
AbstractforThe role of immune checkpoint inhibition in triple negative breast cancer | Full Text | References | PDF (356.2 KB) | EPUB
  • 476 Views
  • 0 CrossRef citations
  • 0Altmetric
Review Article
Treatment optimization in early triple negative breast cancer
Elias Kotteas, Luca Boscolo Bielo, Carmine Valenza, Celeste Santoro, Chrysanthi Koukoutzeli, Dario Trapani & Giuseppe Curigliano
Pages: 1107-1116
Published online: 26 Oct 2023
AbstractforTreatment optimization in early triple negative breast cancer | Full Text | References | PDF (326.9 KB) | EPUB
  • 338 Views
  • 0 CrossRef citations
  • 0Altmetric

Explore articles

Explore the most recently published articles

Nomogram and calculator for predicting the prognosis of patients with giant hepatocellular carcinoma
Wanjin Chen et al.
Article | Published online: 17 Jun 2024
The incidence and relative risk of major adverse cardiovascular events and hypertension in patients treated with immune checkpoint inhibitors plus tyrosine-kinase inhibitors for solid tumors: a systemic review and meta-analysis
Chiara Ciccarese et al.
Review Article | Published online: 16 Jun 2024
Open Access
Immunotherapy in MMR-d/MSI-H recurrent/metastatic endometrial cancer
Renata Pacholczak-Madej et al.
Review Article | Published online: 14 Jun 2024
Relacorilant in recurrent ovarian cancer: clinical evidence and future perspectives
Elena Giudice et al.
Review Article | Published online: 11 Jun 2024
Open Access
View all latest articles